Bayer Aktiengesellschaft (ETR:BAYN)
36.98
-0.45 (-1.20%)
May 8, 2026, 5:35 PM CET
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 87,280 employees as of December 31, 2025. The number of employees decreased by 4,584 or -4.99% compared to the previous year.
Employees
87,280
Change
-4,584
Growth
-4.99%
Revenue / Employee
€522,170
Profits / Employee
€41,476
Market Cap
36.33B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 87,280 | -4,584 | -4.99% |
| Sep 30, 2025 | 88,502 | -5,743 | -6.09% |
| Jun 30, 2025 | 89,556 | -7,011 | -7.26% |
| Mar 31, 2025 | 90,885 | -7,304 | -7.44% |
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Sep 30, 2024 | 94,245 | -6,628 | -6.57% |
| Jun 30, 2024 | 96,567 | -5,481 | -5.37% |
| Mar 31, 2024 | 98,189 | -3,546 | -3.49% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Sep 30, 2023 | 100,873 | -1,423 | -1.39% |
| Jun 30, 2023 | 102,048 | 134 | 0.13% |
| Mar 31, 2023 | 101,735 | 982 | 0.97% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Sep 30, 2022 | 102,296 | 2,482 | 2.49% |
| Jun 30, 2022 | 101,914 | 2,475 | 2.49% |
| Mar 31, 2022 | 100,753 | 1,424 | 1.43% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Sep 30, 2021 | 99,814 | -804 | -0.80% |
| Jun 30, 2021 | 99,439 | -1,729 | -1.71% |
| Mar 31, 2021 | 99,329 | -2,872 | -2.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,583 |
| Fresenius Medical Care AG | 108,165 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| Fielmann Group AG | 24,363 |
| Drägerwerk AG & Co. KGaA | 16,033 |
| Sartorius Aktiengesellschaft | 14,242 |
| Ottobock SE & Co. KGaA | 10,365 |
Bayer Aktiengesellschaft News
- 2 days ago - Bayer reports REVEAL study met primary endpoints - TheFly
- 2 days ago - Bayer to acquire Perfuse Therapeutics for $300M upfront - TheFly
- 2 days ago - Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis - Business Wire
- 3 days ago - Bayer and bp Form Strategic Alliance to Jointly Scale Camelina as Intermediate Crop for Biofuels - Business Wire
- 3 days ago - Bayer says its experimental blood thinner cuts risk and severity of repeat strokes - Reuters
- 3 days ago - Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion - WSJ
- 3 days ago - Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal - Reuters
- 3 days ago - Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline - Business Wire